Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.57
-0.13 (-1.34%)
At close: Jan 30, 2025, 4:00 PM
9.51
-0.06 (-0.63%)
After-hours: Jan 30, 2025, 4:10 PM EST
Anavex Life Sciences Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AVXL stock have an average target of 44, with a low estimate of 42 and a high estimate of 46. The average target predicts an increase of 359.77% from the current stock price of 9.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AVXL stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +380.67% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +338.87% | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +338.87% | Jan 21, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +380.67% | Jan 15, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $46 | Strong Buy | Maintains | $46 | +380.67% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
678.43M
EPS This Year
-0.66
from -0.52
EPS Next Year
5.21
from -0.66
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 698.4M | 1.1B | ||
| Avg | n/a | 678.4M | 1.1B | ||
| Low | n/a | 651.8M | 1.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 60.5% | ||
| Avg | - | - | 55.9% | ||
| Low | - | - | 49.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.59 | 5.37 | 7.83 | ||
| Avg | -0.66 | 5.21 | 7.61 | ||
| Low | -0.72 | 5.01 | 7.31 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 50.3% | ||
| Avg | - | - | 46.0% | ||
| Low | - | - | 40.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.